- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 27/06 - Antiglaucoma agents or miotics
Patent holdings for IPC class A61P 27/06
Total number of patents in this class: 1698
10-year publication summary
|
84
|
63
|
97
|
103
|
106
|
142
|
128
|
96
|
115
|
8
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Allergan, Inc. | 2441 |
142 |
| Santen Pharmaceutical Co., Ltd. | 626 |
75 |
| Nicox S.A. | 150 |
33 |
| Kowa Company, Ltd. | 1193 |
21 |
| Senju Pharmaceutical Co., Ltd. | 238 |
20 |
| Alcon, Inc. | 5173 |
18 |
| Regeneron Pharmaceuticals, Inc. | 3980 |
17 |
| The Regents of the University of California | 19503 |
15 |
| Alcon Research, Ltd. | 352 |
15 |
| Aerie Pharmaceuticals, Inc. | 62 |
13 |
| Ono Pharmaceutical Co., Ltd. | 435 |
13 |
| Takeda Pharmaceutical Company Limited | 2945 |
12 |
| Bausch & Lomb Incorporated | 1139 |
12 |
| Daiichi Sankyo Company, Limited | 1863 |
11 |
| D. Western Therapeutics Institute, Inc. | 22 |
10 |
| Japan Tobacco Inc. | 3483 |
10 |
| Novartis AG | 11276 |
9 |
| Eye Therapies LLC | 39 |
9 |
| Astellas Pharma Inc. | 1123 |
8 |
| Dainippon Sumitomo Pharma Co., Ltd. | 214 |
8 |
| Other owners | 1227 |